MEPs reject US-style direct advertising of drugs
BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7371.990/a (Published 02 November 2002) Cite this as: BMJ 2002;325:990- Rory Watson
- Brussels
Members of the European parliament have categorically rejected tentative plans to allow pharmaceutical companies to provide information on drugs directly to the public in the European Union.
As part of its proposals to update existing EU legislation on the approval and marketing of drugs, the European Commission had suggested a five year pilot scheme during which firms could supply data directly to patients on three common illnesses: diabetes, asthma, and AIDS.
Erkki Liikanen, the European commissioner behind the proposal, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.